Document is current

Article History

Received: 3 April 2024

Accepted: 14 August 2024

First Online: 29 August 2024

Declarations

:

: Ethical approval for this study was obtained from The Ethics Committee in the Capital Region of Denmark (H-20031301), the Danish Medicines Agency (EudraCT-number: 2020-002329-27), and Capital Region at Knowledge Center for Data Reviews (P-2020-1193). Written informed consent will be obtained from all subjects before the study.

: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request. Permission for publication of anonymized data is given by patients in the consent form.

: HRS has received honoraria as a speaker and consultant from Lundbeck AS, Denmark, and as editor (Neuroimage Clinical) from Elsevier Publishers, Amsterdam, The Netherlands. He has received royalties as book editor from Springer Publishers, Stuttgart, Germany, Oxford University Press, Oxford, UK, and Gyldendal Publishers, Copenhagen, Denmark. HC has received honoraria as a speaker from Bayer, Pfizer, and BMS, and as senior guest editor from American Heart Association (Stroke). She has received royalties from Gyldendal Publishers, Copenhagen, Denmark. The other authors declare no potential conflict of interest with respect to the research, authorship, and/or publication of this article.